Dr. William Gray of Lankenau Institute for Medical Research, part of Main Line Health, guided research presented at cardiology conference and published by Lancet
News | Peripheral Artery Disease (PAD)
Study Organized by Main Line Health Researchers Reverses FDA Warning on Vital Peripheral Artery Disease Treatment

October 24, 2023 โ€” Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
Figure 1: A PROTECT III study analysis demonstrates that 82.5% of Impella-supported HRPCI patients have features in all three high-risk factor domains โ€“ comorbidities, complex coronary anatomy and adverse hemodynamics.
News | Heart Valve Technology
Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium

October 24, 2023 โ€” Abiomed, part of Johnson & Johnson MedTech[1], announced that novel data from seven research studies ...

Home October 24, 2023
Home
The Aurora EV-ICD system
News | Implantable Cardioverter Defibrillator (ICD)
Medtronic Receives FDA Approval for Extravascular Defibrillator to Treat Abnormal Heart Rhythms, Sudden Cardiac Arrest

October 23, 2023 โ€” Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Cardiovascular Business
Mindrayย Expands Cardiac Biomarker Portfolio with Launch of New Assays

October 23, 2030 โ€” Global medical devices and solutions provider Mindray has announced the introduction and global ...

Home October 23, 2023
Home
The algorithm may help clinicians find atrial fibrillation in people without symptoms
News | Artificial Intelligence
Cedars-Sinai Uses AI to Identify People with Abnormal Heart Rhythms

October 23, 2023 โ€” Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence ...

Home October 23, 2023
Home
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device
News | Hemodynamic Support Devices
Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at TCT23

October 23, 2023 โ€” Supira Medical, Inc., a Shifamed portfolio company, announced that the company's percutaneous ...

Home October 23, 2023
Home
The ALIGN-AR trial is a landmark prospective, single-arm investigation device exemption (IDE) study designed to assess the safety and efficacy of the Trilogy THV System
News | Cardiovascular Clinical Studies
JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023

October 20, 2023 โ€” JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Heart Valve (THV) ...

Home October 20, 2023
Home
Published late-breaking clinical data presented at TCT 2023
News | Cath Lab
Philips Showcases Latest Medical Innovations and Solutions for Patients with Cardiovascular Disease TCT23

October 20, 2023 โ€” Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
Published late-breaking clinical data presented at TCT 2023
News | Heart Failure
Gene Discoveries Could Help Prevent Deadly Coronary Artery Disease

October 20, 2023 โ€” An international team of scientists has identified nearly a dozen genes that contribute to calcium ...

Home October 20, 2023
Home
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
Feature | TCT | By Melinda Taschetta-Millane
TCT23 Late-breakers: Full Schedule Announced

Innovation. Connection. Inspiration. The Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the ...

Home October 20, 2023
Home
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
News | Structural Heart
UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound

October 19, 2023 โ€” The Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for ...

Home October 19, 2023
Home
The CLAAS System to be highlighted daily at TCT, including a live case presentation by Dr. Shephal Doshi
News | Left Atrial Appendage (LAA) Occluders
Conformal Medical to Present One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study at TCT 2023

October 19, 2023 โ€” Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early ...

Home October 19, 2023
Home
Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter treatment of eligible patients with tricuspid regurgitation
News | Structural Heart
Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark

October 19, 2023 โ€” Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system ...

Home October 19, 2023
Home
News | TCT
Results of SAFE-TAVI Clinical Study Anticipated at TCT 2023

October 19, 2023 โ€” OpSens, a medical device cardiology-focused company, has announced that results of the โ€œSAFE-TAVI ...

Home October 19, 2023
Home
Cardiovascular Research Foundation's (CRF) annual scientific symposium, Transcatheter Cardiovascular Therapeutics, TCT 2023, is set for October 23-26 in San Francisco
Feature | TCT | Christine Book
TCT 2023 Leadership Anticipates 'Practice Changing' Findings Ahead of 35th Scientific Symposium

October 18, 2023 โ€” The following is an updated program preview of the Cardiovascular Research Foundation's (CRF) annual ...

Home October 18, 2023
Home
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now